Helixmith Co., Ltd (KOSDAQ:084990)
South Korea · Delayed Price · Currency is KRW 4,470.00
-230.00 (-4.89%)
Jun 10, 2026, 3:30 PM KST
Helixmith Market Cap
Helixmith has a market cap or net worth of 216.42 billion as of June 10, 2026. Its market cap has increased by 69.37% in one year.
Market Cap
216.42B
Enterprise Value
135.36B
Revenue
2.22B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,470.00
Market Cap Chart
Since December 29, 2005, Helixmith's market cap has decreased from 238.64B to 216.42B, a decrease of -9.31%. That is a compound annual growth rate of -0.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 216.42B | -24.44% |
| Dec 30, 2025 | 286.41B | 130.37% |
| Dec 30, 2024 | 124.33B | -51.50% |
| Dec 28, 2023 | 256.37B | -35.45% |
| Dec 29, 2022 | 397.14B | -53.54% |
| Dec 30, 2021 | 854.88B | -3.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SillaJen | 363.01B |
| Genomictree | 297.67B |
| Anterogen.Co.,Ltd. | 264.16B |
| BINEX | 261.47B |
| GC Cell | 258.17B |
| NeoImmuneTech | 247.66B |
| HLB Therapeutics | 245.76B |
| EASY BIO,Inc. | 209.74B |